Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction.

Anand A, Shah ASV, Beshiri A, Jaffe AS, Mills NL.

Clin Chem. 2019 Jan 9. pii: clinchem.2018.298059. doi: 10.1373/clinchem.2018.298059. [Epub ahead of print]

PMID:
30626631
2.

Prevalence, Determinants, and Clinical Associations of High-Sensitivity Cardiac Troponin in Patients Attending Emergency Departments.

Lee KK, Noaman A, Vaswani A, Gibbins M, Griffiths M, Chapman AR, Strachan F, Anand A, McAllister DA, Newby DE, Gray AJ, Mills NL, Shah ASV.

Am J Med. 2019 Jan;132(1):110.e8-110.e21. doi: 10.1016/j.amjmed.2018.10.002. Epub 2018 Oct 26.

3.

High-Sensitivity Cardiac Troponin I Levels in Normal and Hypertensive Pregnancy.

Ravichandran J, Woon SY, Quek YS, Lim YC, Noor EM, Suresh K, Vigneswaran R, Vasile V, Shah A, Mills NL, Sickan J, Beshiri A, Jaffe AS.

Am J Med. 2018 Nov 30. pii: S0002-9343(18)31140-9. doi: 10.1016/j.amjmed.2018.11.017. [Epub ahead of print]

PMID:
30503877
4.

Novel high-sensitivity cardiac troponin I assay in patients with suspected acute coronary syndrome.

Chapman AR, Fujisawa T, Lee KK, Andrews JP, Anand A, Sandeman D, Ferry AV, Stewart S, Marshall L, Strachan FE, Gray A, Newby DE, Shah ASV, Mills NL.

Heart. 2018 Nov 15. pii: heartjnl-2018-314093. doi: 10.1136/heartjnl-2018-314093. [Epub ahead of print]

5.

Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

Chauhan A, Lalor T, Watson S, Adams D, Farrah TE, Anand A, Kimmitt R, Mills NL, Webb DJ, Dhaun N, Kalla R, Adams A, Vatn S, Bonfliglio F, Nimmo E, Kennedy N, Ventham N, Vatn M, Ricanek P, Halfvarson J, Soderhollm J, Pierik M, Torkvist L, Gomollon F, Gut I, Jahnsen J, Satsangi J, Body R, Almashali M, McDowell G, Taylor P, Lacey A, Rees A, Ludgate, Dayan C, Lazarus J, Nelson S, Okosieme O, Corcoran D, Young R, Ciadella P, McCartney P, Bajrangee A, Hennigan B, Collison D, Carrick D, Shaukat A, Good R, Watkins S, McEntegart M, Watt J, Welsh P, Sattar N, McConnachie A, Oldroyd K, Berry C, Parks T, Auckland K, Mentzer AJ, Kado J, Mirabel MM, Kauwe JK, Robson KJ, Mittal B, Steer AC, Hill AVS, Akbar M, Forrester M, Virlan AT, Gilmour A, Wallace C, Paterson C, Reid D, Siebert S, Porter D, Liversidge J, McInnes I, Goodyear C, Athwal V, Pritchett J, Zaitoun A, Irving W, Guha IN, Hanley NA, Hanley KP, Briggs T, Reynolds J, Rice G, Bondet V, Bruce E, Crow Y, Duffy D, Parker B, Bruce I, Martin K, Pritchett J, Aoibheann Mullan M, Llewellyn J, Athwal V, Zeef L, Farrow S, Streuli C, Henderson N, Friedman S, Hanley N, Hanley KP.

QJM. 2018 Dec 1;111(12):920-924. doi: 10.1093/qjmed/hcy193. No abstract available.

PMID:
30418642
6.

Unrecognised myocardial infarction and its relationship to outcome in critically ill patients with cardiovascular disease.

Docherty AB, Alam S, Shah AS, Moss A, Newby DE, Mills NL, Stanworth SJ, Lone NI, Walsh TS; TROPICCAL Investigators.

Intensive Care Med. 2018 Dec;44(12):2059-2069. doi: 10.1007/s00134-018-5425-0. Epub 2018 Oct 29.

PMID:
30374693
7.

High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome.

Chapman AR, Hesse K, Andrews J, Ken Lee K, Anand A, Shah ASV, Sandeman D, Ferry AV, Jameson J, Piya S, Stewart S, Marshall L, Strachan FE, Gray A, Newby DE, Mills NL.

Circulation. 2018 Oct 16;138(16):1654-1665. doi: 10.1161/CIRCULATIONAHA.118.036426.

8.

Response To Letter Regarding Article "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".

Chapman AR, Mills NL.

Circulation. 2018 Sep 11;138(11):1178. doi: 10.1161/CIRCULATIONAHA.118.036021. Epub 2018 Sep 10. No abstract available.

PMID:
30287969
9.

High-Sensitivity Troponin and the Selection of Patients for Cardiac Imaging in the Outpatient Clinic.

Adamson PD, Mills NL.

Clin Chem. 2018 Nov;64(11):1555-1557. doi: 10.1373/clinchem.2018.294629. Epub 2018 Sep 20. No abstract available.

PMID:
30237147
10.

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial.

Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, Sandeman D, Stables CL, Adamson PD, Andrews JPM, Anwar MS, Hung J, Moss AJ, O'Brien R, Berry C, Findlay I, Walker S, Cruickshank A, Reid A, Gray A, Collinson PO, Apple FS, McAllister DA, Maguire D, Fox KAA, Newby DE, Tuck C, Harkess R, Parker RA, Keerie C, Weir CJ, Mills NL; High-STEACS Investigators.

Lancet. 2018 Sep 15;392(10151):919-928. doi: 10.1016/S0140-6736(18)31923-8. Epub 2018 Aug 28.

11.

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease.

Adamson PD, Anderson JA, Brook RD, Calverley PMA, Celli BR, Cowans NJ, Crim C, Dixon IJ, Martinez FJ, Newby DE, Vestbo J, Yates JC, Mills NL.

J Am Coll Cardiol. 2018 Sep 4;72(10):1126-1137. doi: 10.1016/j.jacc.2018.06.051. Erratum in: J Am Coll Cardiol. 2018 Oct 30;72(18):2282.

12.

Coronary CT Angiography and 5-Year Risk of Myocardial Infarction.

SCOT-HEART Investigators, Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, Flather M, Forbes J, Hunter A, Lewis S, MacLean S, Mills NL, Norrie J, Roditi G, Shah ASV, Timmis AD, van Beek EJR, Williams MC.

N Engl J Med. 2018 Sep 6;379(10):924-933. doi: 10.1056/NEJMoa1805971. Epub 2018 Aug 25.

PMID:
30145934
13.

Comparison between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort.

Welsh P, Preiss D, Shah ASV, McAllister D, Briggs A, Boachie C, McConnachie A, Hayward C, Padmanabhan S, Welsh C, Woodward M, Campbell A, Porteous D, Mills NL, Sattar N.

Clin Chem. 2018 Nov;64(11):1607-1616. doi: 10.1373/clinchem.2018.292086. Epub 2018 Aug 20.

PMID:
30126950
14.

Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV.

Shah ASV, Stelzle D, Lee KK, Beck EJ, Alam S, Clifford S, Longenecker CT, Strachan F, Bagchi S, Whiteley W, Rajagopalan S, Kottilil S, Nair H, Newby DE, McAllister DA, Mills NL.

Circulation. 2018 Sep 11;138(11):1100-1112. doi: 10.1161/CIRCULATIONAHA.117.033369.

PMID:
29967196
15.

High-sensitivity troponin: a barometer for cardiac health.

Lee KK, Mills NL.

Cardiovasc Res. 2018 May 1;114(6):e36-e38. doi: 10.1093/cvr/cvy080. No abstract available.

PMID:
29897496
16.

High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris.

Adamson PD, Hunter A, Madsen DM, Shah ASV, McAllister DA, Pawade TA, Williams MC, Berry C, Boon NA, Flather M, Forbes J, McLean S, Roditi G, Timmis AD, van Beek EJR, Dweck MR, Mickley H, Mills NL, Newby DE.

Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004227. doi: 10.1161/CIRCOUTCOMES.117.004227.

PMID:
29444926
17.

Endothelin antagonism reduces circulating galectin-3 in patients with proteinuric chronic kidney disease.

Farrah TE, Anand A, Miller-Hodges E, Mills NL, Webb DJ, Dhaun N.

Kidney Int. 2018 Jan;93(1):270. doi: 10.1016/j.kint.2017.10.009. No abstract available.

PMID:
29291821
18.

Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery.

Alam SR, Stirrat C, Spath N, Zamvar V, Pessotto R, Dweck MR, Moore C, Semple S, El-Medany A, Manoharan D, Mills NL, Shah A, Mirsadraee S, Newby DE, Henriksen PA.

J Cardiothorac Surg. 2017 Dec 16;12(1):115. doi: 10.1186/s13019-017-0681-6.

19.

Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis.

Anand A, Chin C, Shah ASV, Kwiecinski J, Vesey A, Cowell J, Weber E, Kaier T, Newby DE, Dweck M, Marber MS, Mills NL.

Heart. 2018 Jul;104(13):1101-1108. doi: 10.1136/heartjnl-2017-312257. Epub 2017 Dec 1.

20.

Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury.

Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, McAllister DA, Strachan FE, Newby DE, Mills NL.

Circulation. 2018 Mar 20;137(12):1236-1245. doi: 10.1161/CIRCULATIONAHA.117.031806. Epub 2017 Nov 17.

21.

Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.

Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, Sörensen NA, Westermann D, Buijs MM, Verdel GJE, Pickering JW, Than MP, Twerenbold R, Badertscher P, Sabti Z, Mueller C, Anand A, Adamson P, Strachan FE, Ferry A, Sandeman D, Gray A, Body R, Keevil B, Carlton E, Greaves K, Korley FK, Metkus TS, Sandoval Y, Apple FS, Newby DE, Shah ASV, Mills NL.

JAMA. 2017 Nov 21;318(19):1913-1924. doi: 10.1001/jama.2017.17488. Review. Erratum in: JAMA. 2018 Mar 20;319(11):1168. Soerensen NA [corrected to Sorensen NA].

22.

Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study.

Shah ASV, Sandoval Y, Noaman A, Sexter A, Vaswani A, Smith SW, Gibbins M, Griffiths M, Chapman AR, Strachan FE, Anand A, Denvir MA, Adamson PD, D'Souza MS, Gray AJ, McAllister DA, Newby DE, Apple FS, Mills NL.

BMJ. 2017 Nov 7;359:j4788. doi: 10.1136/bmj.j4788. Erratum in: BMJ. 2018 Jan 31;360:k495.

23.

Endothelial Progenitor Cell Biology and Vascular Recovery Following Transradial Cardiac Catheterization.

Mitchell A, Fujisawa T, Mills NL, Brittan M, Newby DE, Cruden NLM.

J Am Heart Assoc. 2017 Oct 28;6(11). pii: e006610. doi: 10.1161/JAHA.117.006610.

24.

A single blood test to rule out acute coronary syndrome.

Chapman AR, Mills NL.

Heart. 2018 Apr;104(8):632-633. doi: 10.1136/heartjnl-2017-312269. Epub 2017 Oct 27. No abstract available.

25.

High-sensitivity cardiac troponin I and risk of heart failure in patients with suspected acute coronary syndrome: a cohort study.

Stelzle D, Shah ASV, Anand A, Strachan FE, Chapman AR, Denvir MA, Mills NL, McAllister DA.

Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):36-42. doi: 10.1093/ehjqcco/qcx022.

26.

Early diagnosis of acute coronary syndrome.

Katus H, Ziegler A, Ekinci O, Giannitsis E, Stough WG, Achenbach S, Blankenberg S, Brueckmann M, Collinson P, Comaniciu D, Crea F, Dinh W, Ducrocq G, Flachskampf FA, Fox KAA, Friedrich MG, Hebert KA, Himmelmann A, Hlatky M, Lautsch D, Lindahl B, Lindholm D, Mills NL, Minotti G, Möckel M, Omland T, Semjonow V.

Eur Heart J. 2017 Nov 1;38(41):3049-3055. doi: 10.1093/eurheartj/ehx492.

PMID:
29029109
27.

Sodium channel current loss of function in induced pluripotent stem cell-derived cardiomyocytes from a Brugada syndrome patient.

Selga E, Sendfeld F, Martinez-Moreno R, Medine CN, Tura-Ceide O, Wilmut SI, Pérez GJ, Scornik FS, Brugada R, Mills NL.

J Mol Cell Cardiol. 2018 Jan;114:10-19. doi: 10.1016/j.yjmcc.2017.10.002. Epub 2017 Oct 9.

28.

Nanomaterials Versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge.

Stone V, Miller MR, Clift MJD, Elder A, Mills NL, Møller P, Schins RPF, Vogel U, Kreyling WG, Alstrup Jensen K, Kuhlbusch TAJ, Schwarze PE, Hoet P, Pietroiusti A, De Vizcaya-Ruiz A, Baeza-Squiban A, Teixeira JP, Tran CL, Cassee FR.

Environ Health Perspect. 2017 Oct 10;125(10):106002. doi: 10.1289/EHP424. Review.

29.

Differences in relative and absolute effectiveness of oral P2Y 12 inhibition in men and women: a meta-analysis and modelling study.

Lee KK, Welton N, Shah AS, Adamson PD, Dias S, Anand A, Newby DE, Mills NL, McAllister DA.

Heart. 2018 Apr;104(8):657-664. doi: 10.1136/heartjnl-2017-312003. Epub 2017 Oct 5.

30.

High-Sensitivity Cardiac Troponin and the Risk Stratification of Patients With Renal Impairment Presenting With Suspected Acute Coronary Syndrome.

Miller-Hodges E, Anand A, Shah ASV, Chapman AR, Gallacher P, Lee KK, Farrah T, Halbesma N, Blackmur JP, Newby DE, Mills NL, Dhaun N.

Circulation. 2018 Jan 30;137(5):425-435. doi: 10.1161/CIRCULATIONAHA.117.030320. Epub 2017 Oct 4.

31.

Correction to"Inhaled Nanoparticles Accumulate at Sites of Vascular Disease".

Miller MR, Raftis JB, Langrish JP, McLean SG, Samutrtai P, Connell SP, Wilson S, Vesey AT, Fokkens PHB, Boere AJF, Krystek P, Campbell CJ, Hadoke PWF, Donaldson K, Cassee FR, Newby DE, Duffin R, Mills NL.

ACS Nano. 2017 Oct 24;11(10):10623-10624. doi: 10.1021/acsnano.7b06327. Epub 2017 Oct 4. No abstract available.

PMID:
28976185
32.

The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis.

Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, Shenkin S, Mills NL.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):123-132. doi: 10.1093/ehjqcco/qcw030. Review.

33.

Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus.

Noh RM, Venkatasubramanian S, Daga S, Langrish J, Mills NL, Lang NN, Hoffmann E, Waterhouse B, Newby DE, Frier BM.

Open Heart. 2017 Sep 2;4(2):e000647. doi: 10.1136/openhrt-2017-000647. eCollection 2017.

34.

Response by Hunter and Mills to Letters Regarding Article, "Fire Simulation and Cardiovascular Health in Firefighters".

Hunter AL, Mills NL.

Circulation. 2017 Sep 5;136(10):976-977. doi: 10.1161/CIRCULATIONAHA.117.030100. No abstract available.

PMID:
28874426
35.

Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial.

Adamson PD, Hunter A, Williams MC, Shah ASV, McAllister DA, Pawade TA, Dweck MR, Mills NL, Berry C, Boon NA, Clark E, Flather M, Forbes J, McLean S, Roditi G, van Beek EJR, Timmis AD, Newby DE.

Heart. 2018 Feb;104(3):207-214. doi: 10.1136/heartjnl-2017-311508. Epub 2017 Aug 27.

36.

High-sensitivity cardiac troponin I assays in the diagnosis of acute myocardial infarction.

Chapman AR, Newby DE, Mills NL.

Heart Asia. 2017 Apr 7;9(1):88-89. doi: 10.1136/heartasia-2016-010867. eCollection 2017. No abstract available.

37.

Inhaled Nanoparticles Accumulate at Sites of Vascular Disease.

Miller MR, Raftis JB, Langrish JP, McLean SG, Samutrtai P, Connell SP, Wilson S, Vesey AT, Fokkens PHB, Boere AJF, Krystek P, Campbell CJ, Hadoke PWF, Donaldson K, Cassee FR, Newby DE, Duffin R, Mills NL.

ACS Nano. 2017 May 23;11(5):4542-4552. doi: 10.1021/acsnano.6b08551. Epub 2017 Apr 26. Erratum in: ACS Nano. 2017 Oct 24;11(10):10623-10624.

38.

Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women.

Shah ASV, Ferry AV, Mills NL.

Curr Cardiol Rep. 2017 May;19(5):40. doi: 10.1007/s11886-017-0839-9. Review.

39.

Fire Simulation and Cardiovascular Health in Firefighters.

Hunter AL, Shah AS, Langrish JP, Raftis JB, Lucking AJ, Brittan M, Venkatasubramanian S, Stables CL, Stelzle D, Marshall J, Graveling R, Flapan AD, Newby DE, Mills NL.

Circulation. 2017 Apr 4;135(14):1284-1295. doi: 10.1161/CIRCULATIONAHA.116.025711.

40.

18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study.

Vesey AT, Jenkins WS, Irkle A, Moss A, Sng G, Forsythe RO, Clark T, Roberts G, Fletcher A, Lucatelli C, Rudd JH, Davenport AP, Mills NL, Al-Shahi Salman R, Dennis M, Whiteley WN, van Beek EJ, Dweck MR, Newby DE.

Circ Cardiovasc Imaging. 2017 Mar;10(3). pii: e004976. doi: 10.1161/CIRCIMAGING.116.004976.

41.

High sensitive TROponin levels In Patients with Chest pain and kidney disease: A multicenter registry - The TROPIC study.

Ballocca F, D'Ascenzo F, Moretti C, Diletti R, Budano C, Palazzuoli A, Reed MJ, Palmerini T, Dudek D, Galassi A, Omedè P, Mieghem NM, Ferenbach D, Pavani M, Della Riva D, Mills NL, Van Domburgh RT, Mariani A, Dziewierz A, di Cuia M, Jan van Geuns R, Zijlstra F, Bergerone S, Marra S, Biondi Zoccai G, Gaita F.

Cardiol J. 2017;24(2):139-150. doi: 10.5603/CJ.a2017.0025. Epub 2017 Mar 10.

42.

High-Sensitivity Troponin I Is Associated With High-Risk Plaque and MACE in Stable Coronary Artery Disease.

Brown AJ, Shah ASV, West NEJ, Costopoulos C, Orzalkiewicz M, Newby DE, Bennett MR, Mills NL, Calvert PA.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1200-1203. doi: 10.1016/j.jcmg.2016.09.025. Epub 2017 Jan 18. No abstract available.

43.

Early Rule-Out and Rule-In Strategies for Myocardial Infarction.

Cullen LA, Mills NL, Mahler S, Body R.

Clin Chem. 2017 Jan;63(1):129-139. doi: 10.1373/clinchem.2016.254730. Epub 2016 Oct 10. Review.

44.

Comparison of the Efficacy and Safety of Early Rule-Out Pathways for Acute Myocardial Infarction.

Chapman AR, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, Andrews J, Tan S, Cheng SF, D'Souza M, Orme K, Strachan FE, Nestelberger T, Twerenbold R, Badertscher P, Reichlin T, Gray A, Shah ASV, Mueller C, Newby DE, Mills NL.

Circulation. 2017 Apr 25;135(17):1586-1596. doi: 10.1161/CIRCULATIONAHA.116.025021. Epub 2016 Dec 29.

45.

Should the 1h algorithm for rule in and rule out of acute myocardial infarction be used universally?

Crea F, Jaffe AS, Collinson PO, Hamm CW, Lindahl B, Mills NL, Thygesen K, Mueller C, Patrono C, Roffi M; 2015 ESC NSTE-ACS Guidelines Task Force.

Eur Heart J. 2016 Nov 21;37(44):3316-3323. doi: 10.1093/eurheartj/ehw282. No abstract available.

PMID:
28007934
46.

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.

Ford I, Shah AS, Zhang R, McAllister DA, Strachan FE, Caslake M, Newby DE, Packard CJ, Mills NL.

J Am Coll Cardiol. 2016 Dec 27;68(25):2719-2728. doi: 10.1016/j.jacc.2016.10.020.

47.

Point: The Use of Sex-Specific Cutpoints for High-Sensitivity Cardiac Troponin Assays.

Cullen LA, Mills NL.

Clin Chem. 2017 Jan;63(1):261-263. doi: 10.1373/clinchem.2016.254672. Epub 2016 Nov 28. No abstract available.

48.

Appropriate Use of High-Sensitivity Cardiac Troponin Levels in Patients With Suspected Acute Myocardial Infarction.

Chapman AR, Shah AS, Mills NL.

JAMA Cardiol. 2017 Feb 1;2(2):228. doi: 10.1001/jamacardio.2016.4229. No abstract available.

PMID:
27893053
49.

Rapid Rule-Out of Acute Myocardial Injury Using a Single High-Sensitivity Cardiac Troponin I Measurement.

Sandoval Y, Smith SW, Shah AS, Anand A, Chapman AR, Love SA, Schulz K, Cao J, Mills NL, Apple FS.

Clin Chem. 2017 Jan;63(1):369-376. doi: 10.1373/clinchem.2016.264523. Epub 2016 Nov 3.

50.

Assessment and classification of patients with myocardial injury and infarction in clinical practice.

Chapman AR, Adamson PD, Mills NL.

Heart. 2017 Jan 1;103(1):10-18. doi: 10.1136/heartjnl-2016-309530. Epub 2016 Nov 2. Review.

Supplemental Content

Loading ...
Support Center